Osteoporosis, a metabolic bone disease characterized by low bone density and an increased risk of fracture, is a major public health concern in Canada and worldwide.
With a growing and aging Canadian population, the prevalence of osteoporosis is predicted to increase.1
The main public health challenge lies in the fractures associated with the disease.
Such fractures are associated with significant morbidity, mortality and costs.1
Such fractures are associated with significant morbidity, mortality and costs.1
